Human cardiovascular effects of a new generation conducted electrical weapon.
Dr. Jeffrey Ho [this guy], et al
(FAIR USE/FAIR DEALING claimed: education / public safety)
OBJECTIVES: ...New Generation CEW (NGCEW) technology has been developed that uses a different circuit and multiple cartridges that can be simultaneously deployed. The objective of this study is to examine the cardiovascular effects of the NGCEW in different deployment possibilities.
METHODS: This was a prospective study of human subjects during NGCEW training courses...
RESULTS: Initially, a 1st version NGCEW (NGCEWv1) that was in the final stages of manufacturer verification was used at the training courses. It had not been publicly released. During a NGCEWv1 exposure with 2 probes, there was an apparent brief episode of cardiac capture. Testing was halted and the manufacturer was notified. The device was redesigned and the study continued when a redesigned, 2nd version (NGCEWv2) was used. The NGCEW1 was studied in 8 subjects. ...
CONCLUSIONS: An apparent brief myocardial capture event occurred ...
The description of the "NGCEW" sounds like the X3 (elsewhere claimed to have 40% less charge than the X26).
Cardiac capture in at least one of eight subjects, even in ideal circumstances.
1) Obviously, those that design tasers cannot predict the results. This product was in the "final stages" of test and was being used in a "training session". The vast ignorance and hubris of Taser International are revealed.
It's fricken amateur hour in the electro-torture (sometimes to death) business.
The safety margin of tasers is obviously vastly lower than anticipated or claimed.
With a sample size of just eight, using a newly-designed taser that presumably has a safer waveform than the X26, probably under ideal conditions, probably with perfectly-fit subjects, to have one episode of cardiac capture is obviously statistically-inconsistent with the previous claims of safety.
"15-to-1 safety margin" ...my ass.